LOW-VOLUME · SEX-BALANCED

phenelzine Side Effects

phenelzine (also sold as Nardil) is a LOW-VOLUME FAERS extract #470 of 524 by FAERS report count. Still opens on SEX-BALANCED: 62% of sex-coded reports are female (889 F / 556 M).

Data updated 2026-05-15

1,551
FAERS reports

Thinner FAERS book - still a temporal association ledger, not proof of cause. Methodology.

phenelzine reporting skew - 62% of sex-coded reports are female (889 F / 556 M). Volume band LOW-VOLUME #470 of 524 by FAERS report count; caseload SIGNAL.

Thinner FAERS extract for phenelzine (Nardil) (1,551 reports #470 of 524 by FAERS report count). 62% of sex-coded reports are female (889 F / 556 M). Sparse books still carry named reaction rows when present; not medical advice.

Counts from the openFDA FAERS extract (2004–2025). Stamps SIGNAL · DEATH-MARKED · HOSP-MID · SEX-BALANCED.

DEPRESSION leads 187 of 1,551 reports

DEPRESSION
187
HEADACHE
136
ANXIETY
129
WEIGHT INCREASED
120
INSOMNIA
104
DIZZINESS
99
DRUG INTERACTION
99
PHARMACEUTICAL PRODUCT COMPLAINT
97
FATIGUE
94
FEELING ABNORMAL
89
MALAISE
78
NAUSEA
77
HYPERTENSION
76
FALL
61
SOMNOLENCE
57
WEIGHT DECREASED
56
CONDITION AGGRAVATED
52
ASTHENIA
51
SUICIDAL IDEATION
51

Who reports · age peak 45-64 (SEX-BALANCED)

Sex coding · SEX-BALANCED

Female 889 (61%)
Male 556 (38%)
Unknown 8

Age peak 45-64 (352 reports)

0-17 3 (0%)
18-44 125 (17%)
45-64 352 (47%)
65-74 204 (27%)
75+ 65 (9%)

Reporting taper since 2004 peak

2004 2025

Reactions in Death Reports

Death appears on 41 reports (2.6% - MARKED). Reactions below co-occur in those rows only.

Reaction Reports
DEATH 9
COMPLETED SUICIDE 7
CONTRAINDICATED PRODUCT ADMINISTERED 7
DRUG DOSE TITRATION NOT PERFORMED 6
HAEMORRHAGE INTRACRANIAL 6
HYPERTENSIVE CRISIS 6
PRODUCT PRESCRIBING ERROR 6
POTENTIATING DRUG INTERACTION 5
DRUG INTERACTION 4
HAEMORRHAGE 3
SEROTONIN SYNDROME 3
ADVERSE DRUG REACTION 2
AGITATION 2
COMA 2
CONDITION AGGRAVATED 2
CONFUSIONAL STATE 2
DIARRHOEA 2
HYPERHIDROSIS 2
HYPOTENSION 2
MEDICATION ERROR 2

Reactions in Hospitalization Reports

Hospitalization mid-share (325, 21.0%). Co-reported reactions:

Reaction Reports
DEPRESSION 54
DRUG INTERACTION 43
ANXIETY 42
HEADACHE 34
PHARMACEUTICAL PRODUCT COMPLAINT 30
INSOMNIA 29
MALAISE 28
DIZZINESS 26
FALL 25
CONFUSIONAL STATE 24
HYPERTENSION 24
SEROTONIN SYNDROME 24
FATIGUE 22
HYPOTENSION 22
WEIGHT DECREASED 22
FEELING ABNORMAL 20
SUICIDAL IDEATION 19
SOMNOLENCE 18
WEIGHT INCREASED 18
How to read phenelzine FAERS figures (SIGNAL · DEATH-MARKED · HOSP-MID)

FAERS holds 1,551 voluntary reports linked to phenelzine (Nardil), 2004-2025. Death is listed on 41 (2.6%). Hospitalization appears on 325 (21.0%). Top co-reported indication: Depression.

Sparse extract - named reactions and SEX-BALANCED skew still differ by drug; not a complete safety profile.

Read with phenelzine

Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-MARKED · HOSP-MID stamps.